Leveraging SBDD in protein therapeutic development: antibody engineering

Gary L Gilliland1, Jinquan Luo, Omid Vafa

  • 1Centocor R&D Inc., Radnor, PA, USA. ggillila@its.jnj.com

Summary

Antibody engineering advances protein therapeutics, enhancing efficacy and stability. State-of-the-art methods like humanization and Fc engineering are crucial for developing next-generation antibody drugs.

Related Concept Videos